Search Results

ONWARD Medical N.V. announces that the Company will be highlighted in a main stage keynote at HLTH Europe, a premier event for digital health leaders.

Sinopia Biosciences, Inc. announced today that it has been awarded a Small Business Innovation Research (SBIR) grant from the National Institute of General Medical Sciences (NIGMS) to advance its computational drug discovery LEarn And DiScover (LEADS™) platform and explore applications in oncology and immunology.

Ascential Medical & Life Sciences, a leader in end-to-end solutions for complex medical & life science devices that provides total commercialization services from ideation to scaled manufacturing, announced the appointment of Vinod Mirchandani as Chief Technology Officer.

NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative medical imaging technology company, today announced that data from five studies supporting the AI Cardiac Solution (HealthCCSng) of its subsidiary, Nanox AI, will be presented at the 19th Annual Meeting of the Society of Cardiovascular Computed Tomography (SCCT), being held July 18-21 in Washington, D.C.

Science Corporation has acquired the IP and related assets for the PRIMA retinal implant.

Pattern Computer®, Inc. (“Pattern” or “the Company”) today announced the availability of the first paper produced by a research collaboration with Lawrence Berkeley National Laboratory (LBNL) and Los Alamos National Laboratory (LANL) and funded by the U.S. Department of Energy and the Defense Threat Reduction Agency (DTRA), which addresses the clear and critical need for pathogen agnostic diagnostics that can be quickly and effectively performed at point of need.

Bionano Genomics, Inc. announced significant upgrades to its suite of computational tools for comprehensive cancer analysis.

Ascential Medical & Life Sciences announced the appointment of Anupam Girdhar as divisional CEO. A business leader with 25 years of operational and strategic experience, Mr. Girdhar has managed complex life science tools and medical devices businesses.

Brain–computer interface company Precision Neuroscience Corporation announced the launch of two new clinical study sites, at Mount Sinai Health System and Perelman School of Medicine at the University of Pennsylvania.